# Novel genetic assessments for cancer patients: where does medical imaging stand in the future of personalised medicine?

**Authors:** Sally L. Ayesa

PMC · DOI: 10.1002/jmrs.762 · Journal of Medical Radiation Sciences · 2024-02-15

## TL;DR

The paper explores how medical imaging might adapt as new genetic technologies shape personalized cancer care.

## Contribution

It highlights the evolving role of medical imaging in the context of novel genetic assessments for cancer patients.

## Key findings

- Advances in genetic assessments are transforming cancer care.
- Medical imaging's role may shift with new technologies like circulating tumour DNA evaluation.

## Abstract

As our understanding of genetics in cancer care improves, the role of personalised medicine for patients continues to grow. With the increasing emergence of novel technologies for patient assessment, such as the evaluation of circulating tumour DNA, we must reflect on the potentially changing role that medical imaging will play in the future of optimal patient care.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Diseases:** cancer (MESH:D009369)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10920931/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10920931/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC10920931/full.md

---
Source: https://tomesphere.com/paper/PMC10920931